Prevalence of Significant Liver Fibrosis and Inflammation in Chronic HBV Infected Patients in Grey Zone
NCT05483049 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2022-08-10
Summary
To explore whether normal alanine aminotransferase (ALT) is associated with liver injury in a cohort of hepatitis B virus (HBV) infected patients in grey zone
Conditions
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Principal Investigators
-
Hui Wang · Ruijin Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2023-03-31
- Completion
- 2023-08-31
More Related Trials
-
Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis
NCT03386890 ·Status: UNKNOWN
-
Quantification of Hepatic Steatosis With Different Ultrasound Frequency
NCT05855239 ·Status: ACTIVE_NOT_RECRUITING
-
Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
NCT05974904 ·Status: RECRUITING
-
Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
NCT01695083 ·Status: COMPLETED
-
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
NCT06779058 ·Status: RECRUITING
-
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
NCT01747772 ·Status: COMPLETED ·Phase: NA
-
Systemic Inflammation in Liver Cirrhosis
NCT04850534 ·Status: COMPLETED
-
Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation
NCT03176290 ·Status: COMPLETED
-
Association Between Serum Ferritin Level and Severity of Liver Disease and Development of HCC in Cirrhotic Patients
NCT05401890 ·Status: UNKNOWN
-
Assessment of Liver Fibrosis and Prognosis in Chinese Patients With CHB Infection Using STE/STQ Elastography
NCT03530657 ·Status: UNKNOWN
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B
NCT02313649 ·Status: COMPLETED
-
Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
NCT02860884 ·Status: COMPLETED
-
The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis
NCT07151885 ·Status: RECRUITING ·Phase: NA
-
Accuracy of RTE for Evaluating Hepatic Fibrosis in Chronic Hepatitis: a Prospective Multicenter Study
NCT02143180 ·Status: UNKNOWN
-
Steatohepatitis in Chronic Hepatitis B
NCT05317260 ·Status: COMPLETED
-
Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients
NCT03128918 ·Status: UNKNOWN
-
68Ga-FAPI PET/CT in Liver Fibrosis Patients
NCT04533828 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
NCT02344680 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver Disease
NCT03487068 ·Status: UNKNOWN ·Phase: NA
-
Identification of Liver Fibrosis Biomarkers
NCT06819917 ·Status: RECRUITING
-
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
NCT07275554 ·Status: RECRUITING
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients
NCT02793791 ·Status: UNKNOWN ·Phase: NA
-
Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter
NCT06203548 ·Status: RECRUITING ·Phase: NA